Trials / Active Not Recruiting
Active Not RecruitingNCT01888198
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 294 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | (EORTC QLQ-C30) questionnaire | |
| BEHAVIORAL | EuroQol EQ-5D 7-item questionnaire |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2013-06-27
- Last updated
- 2025-07-25
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01888198. Inclusion in this directory is not an endorsement.